Form 4 · Filed May 20, 2026, 01:50 AM UTC
ARTV/Artiva Biotherapeutics, Inc.
Aslan Fred — Chief Executive Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 19, 2026 | S | sell | 27,116 | $9 | $244,253 | 1,535,082 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-231506